News

With two active production facilities, Kraig Labs has established parallel operations designed to ensure continuous rearing cycles of its specialized recombinant spider silk silkworms. This dual-site ...
“Mountain Shot is a crafted experience infused with the natural complexities of mushrooms,” says Jessie Unruh, Director of Marketing for Breckenridge Distillery. “It is a toast to nature, friendship ...
Through this multi-phased transaction, BrainsWay aims to expand its long-term total addressable market.
“These amendments to our credit facility with BMO reflect the confidence in Cannara’s growth strategy and operational performance,” said Zohar Krivorot, President & CEO of Cannara.
InflaRx will also conduct one-on-one investor meetings on September 4th. A link to view the fireside chat live stream and its replay is available here. H.C. Wainwright 27th Annual Global Investment ...
Following these transactions, Mr. Matuszewski owns 1,145,362 shares of BioStem Technologies stock. For more information about the purchases, please visit the OTCID disclosure website HERE under ...
Available webcasts will be accessible on Skye’s website.
About Evoke Pharma, Inc. Evoke is a specialty pharmaceutical company focused primarily on the development of drugs to treat GI disorders and diseases. The company developed, commercialized and markets ...
Castle will also be available for one-on-one investor meetings during the Wells Fargo 20 th Annual Healthcare Conference on Sept. 4, 2025, and the 9 th Annual Lake Street Best Ideas Growth (BIG9) ...
ROCKVILLE, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the “Company”), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the ...
T1DM is an autoimmune disorder characterized by the destruction of beta cells, resulting in an absolute deficiency of insulin ...
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%. En cliquant sur ce lien, vous acceptez l'utilisation de cookies ...